Genmab (Otc) (GMAB) has released an update.
Genmab A/S has actively executed its share buy-back program, purchasing shares between April 29 and May 3, 2024, with the aim to reacquire up to DKK 3.5 billion worth of shares by December 16, 2024. Throughout the reported period, a total of 86,692 shares were bought, amounting to DKK 170,613,911.58, and the company now holds 2.33% of its total share capital as treasury shares. The buy-back program aligns with EU regulations and underlines Genmab’s commitment to returning value to shareholders.
For further insights into GMAB stock, check out TipRanks’ Stock Analysis page.
